Brian Jonas, MD, Discusses FDA Approval of Venclexta® for the Treatment of Newly Diagnosed AML.

Brian Jonas, MD, Discusses FDA Approval of Venclexta® for the Treatment of Newly Diagnosed AML.

Venclexta Data Positive for AMLПодробнее

Venclexta Data Positive for AML

Dr. DiNardo on the Rationale for the Pooled Analysis Evaluating Venetoclax in AMLПодробнее

Dr. DiNardo on the Rationale for the Pooled Analysis Evaluating Venetoclax in AML

Venetoclax-Based Combination Therapies Revolutionize Paradigm for Elderly AMLПодробнее

Venetoclax-Based Combination Therapies Revolutionize Paradigm for Elderly AML

Data on VENCLEXTA reinforcing the efficacyПодробнее

Data on VENCLEXTA reinforcing the efficacy

The importance of venetoclax in newly diagnosed AMLПодробнее

The importance of venetoclax in newly diagnosed AML

How have venetoclax combinations changed the way we treat AML?Подробнее

How have venetoclax combinations changed the way we treat AML?

Dr. Lai on the Potential Benefits of Venetoclax in AMLПодробнее

Dr. Lai on the Potential Benefits of Venetoclax in AML

Brian Jonas, ASCO20: Venetoclax combination treatment in older patients with acute myeloid leukemiaПодробнее

Brian Jonas, ASCO20: Venetoclax combination treatment in older patients with acute myeloid leukemia

Venetoclax for AMLПодробнее

Venetoclax for AML

What is the latest on Venetoclax?Подробнее

What is the latest on Venetoclax?

Continued Five Year Benefit of Venetoclax Plus Rituxamab To Treat Chronic Lymphocytic LeukemiaПодробнее

Continued Five Year Benefit of Venetoclax Plus Rituxamab To Treat Chronic Lymphocytic Leukemia

Safety and efficacy of venetoclax-based regimens for AMLПодробнее

Safety and efficacy of venetoclax-based regimens for AML

Daniel DeAngelo, MD, PhD Discusses Acute Myeloid Leukemia (Full Interview)Подробнее

Daniel DeAngelo, MD, PhD Discusses Acute Myeloid Leukemia (Full Interview)

The Benefits of Venetoclax in CLLПодробнее

The Benefits of Venetoclax in CLL

Venclexta - week 3.Подробнее

Venclexta - week 3.

Venetoclax retreatment for CLLПодробнее

Venetoclax retreatment for CLL

Venetoclax: a lifesaving drug for CLL patientsПодробнее

Venetoclax: a lifesaving drug for CLL patients

Venetoclax + azacitidine in unfit patients with AMLПодробнее

Venetoclax + azacitidine in unfit patients with AML

The power of venetoclaxПодробнее

The power of venetoclax